Medical Press Release - Page 6 of 12 - Medika Life : Keeping you informed

Alterity has secured the worldwide exclusive right to patented technology to develop and commercialise therapies that re-sensitise bacteria to antibiotics

First Hospitals in U.S. Implant Next-gen Cardiac Device to Reduce Stroke Risk

Medika Life - August 8, 2020

The WATCHMAN FLX is the only FDA-approved device for the reduction of stroke risk in patients with non-valvular atrial fibrillation (A Fib).

Lilly commits Insulin Value Program, With $35 Copay Card

Medika Life - September 19, 2020

Anyone with commercial insurance, and those without insurance at all, can continue filling their monthly prescription of Lilly insulins for $35 through this program.

Colchicine Shows 48% Reduction in Future Cardio Issues for Heart Attack Victims

Medika Life - August 30, 2020

Early, in-hospital treatment with colchicine reduces the odds of future cardiovascular problems by 48% in people who have just survived a heart attack

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

LATEST

TRENDING

Medika’s Call for Food Aid for Starving Filipino Children

Lover, the App That Helps Women Reach Orgasm

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

The 50 Most Influential Leaders in Pharmacy 2022 Awards

The Nation’s Only Virtual At-Home Detox Programs from Workit Health Expands

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

FINN Partners Brings Aboard the Pharmacy Podcast Network

South University Announces New MSPA Program at West Palm Beach Campus

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

EDITORS CHOICE

Alterity and UniQuest Partner to Reverse Bacterial Resistance to Antibiotics

First Hospitals in U.S. Implant Next-gen Cardiac Device to Reduce Stroke Risk

Lilly commits Insulin Value Program, With $35 Copay Card

Colchicine Shows 48% Reduction in Future Cardio Issues for Heart Attack Victims

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories